Joke Bilcke

University of Antwerp — Belgium

Medicine · Health Sciences

32h-index3.3kcitations115works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral gastroenteritis research and epidemiology(30), Respiratory viral infections research(26), Pneumonia and Respiratory Infections(20), Influenza Virus Research Studies(19), Hepatitis Viruses Studies and Epidemiology(18)

Publications114 total

MCMARCEL - Belgium
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
MCMARCEL - Belgium
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
MCMARCEL - Belgium
Zenodo (CERN European Organization for Nuclear Research)·2025Open Access
Identifying indicators of “success” in managing the COVID-19 pandemic in Europe: insights from an interdisciplinary expert consultation
Archives of Public Health·2025Open Access
Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infants
2025Open Access
Estimating health utility associated with mental well-being: mapping GHQ-12 responses onto EQ-5D-5L
European Journal of Public Health·2025Open Access
How well do disease-specific studies and WHO-CHOICE cost estimates align? Example of estimating cost per episode of diarrhoea and respiratory syncytial virus in 128 low-income and middle-income countries
BMJ Global Health·2025Open Access
Optimizing influenza vaccine allocation by age using cost-effectiveness analysis: A comparison of 6720 vaccination program scenarios in children and adults in Belgium
Epidemics·2025· 2 citedOpen Access
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: a multi-country analysis
BMC Medicine·2025· 5 citedOpen Access
Kosteneffectiviteit van nieuwe opties voor de preventie van RSV-infecties bij baby’s
2025Open Access
Rapport coût-efficacité de nouvelles options de prévention des infections à VRS chez les nourrissons
2025Open Access
Cost-effectiveness of Abrysvo® and Beyfortus® against RSV infections in Belgian infants
2025Open Access
Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: A multi-country analysis
2024· 2 citedOpen Access
Cost per episode of diarrhea and respiratory syncytial virus (RSV) in 128 low- and middle-income countries: how well do disease-specific and WHO-CHOICE estimates align?
2024· 1 citedOpen Access
Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
The Lancet Regional Health - Americas·2023· 3 citedOpen Access
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach
PLoS Medicine·2023· 15 citedOpen Access
Cervical cancer screening based on urine self-sampling to reach un(der)-screened women: study protocol of the ScreenUrSelf trial
Population Medicine·2023Open Access
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa
BMC Medicine·2023· 30 citedOpen Access
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe
Vaccine·2023· 48 citedOpen Access
Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study
BMC Infectious Diseases·2023· 7 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Philippe Beutels(44), Pierre Van Damme(14), Lander Willem(11), Mark Jit(11), Niel Hens(10), Xiao Li(10), Marina Antillón(8), Andrew J. Pollard(6), Terho Heikkinen(6), Benson Ogunjimi(6), Marc Van Ranst(5), Harry Campbell(5), Harish Nair(5), Louis Bont(5), Federico Martinón‐Torres(5), Germaine Hanquet(5), Virginia E. Pitzer(5), Alexia Kieffer(4), Peter Openshaw(4), Eva Molero(4)